ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
27.25
0.00 (0.00%)
Dec 12, 2025, 4:00 PM EST
ResMed Market Cap
ResMed has a market cap or net worth of $36.89 billion as of December 16, 2025. Its market cap has increased by 0.81% in one year.
Market Cap
36.89B
Enterprise Value
36.35B
Revenue
5.26B
Ranking
n/a
PE Ratio
25.65
Stock Price
$27.25
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 38.59M to 36.89B, an increase of 95,477.39%. That is a compound annual growth rate of 25.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 36.89B | 9.84% |
| Dec 31, 2024 | 33.58B | 32.73% |
| Dec 29, 2023 | 25.30B | -17.24% |
| Dec 30, 2022 | 30.57B | -19.72% |
| Dec 31, 2021 | 38.08B | 23.63% |
| Dec 31, 2020 | 30.80B | 38.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 383.23M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 285.90M |